False elevations in prostate-specific antigen levels affecting patient management

Clin Adv Hematol Oncol. 2004 Sep;2(9):599-601; discussion 602.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / blood*
  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / immunology
  • Adenocarcinoma / radiotherapy
  • Adenocarcinoma / surgery
  • Androgen Antagonists / therapeutic use
  • Antibodies, Heterophile / immunology*
  • Antigen-Antibody Reactions
  • Antigens, Neoplasm / immunology
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Biomarkers, Tumor / blood*
  • Biomarkers, Tumor / immunology
  • Case Management*
  • Cross Reactions
  • False Positive Reactions
  • Follow-Up Studies
  • Humans
  • Immunoenzyme Techniques*
  • Immunoradiometric Assay*
  • Luminescent Measurements
  • Male
  • Microspheres
  • Middle Aged
  • Neoplasm Proteins / blood*
  • Neoplasm Proteins / immunology
  • Neoplasm Recurrence, Local / diagnosis*
  • Prostate-Specific Antigen / blood*
  • Prostate-Specific Antigen / immunology
  • Prostatectomy
  • Prostatic Neoplasms / blood*
  • Prostatic Neoplasms / drug therapy
  • Prostatic Neoplasms / immunology
  • Prostatic Neoplasms / radiotherapy
  • Prostatic Neoplasms / surgery
  • Radiotherapy, Adjuvant
  • Unnecessary Procedures

Substances

  • Androgen Antagonists
  • Antibodies, Heterophile
  • Antigens, Neoplasm
  • Antineoplastic Agents, Hormonal
  • Biomarkers, Tumor
  • Neoplasm Proteins
  • Prostate-Specific Antigen